Defining the Role of Calcium Channel Antagonists in Heart Failure Due to Systolic Dysfunction

Author： Mahé I.   Chassany O.   Grenard A-S.   Caulin C.   Bergmann J-F.  

Publisher： Adis International

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.3, Iss.1, 2003-01, pp. : 33-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The treatment of chronic heart failure due to left ventricular systolic dysfunction

By Gardner R S   McDonagh T A  

Clinical Medicine, Vol. 4, Iss. 1, 2004-01 ,pp. : 18-22

Royal College Of Physicians

Access to resources Recommend Favorite

Pharmacologic Treatment of Heart Failure due to Ventricular Dysfunction by Myocardial Stunning: Potential Role of Levosimendan

By González Martín J. García   Rodríguez Alberto Domínguez  

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 2, 2006-01 ,pp. : 69-75

Adis International

Access to resources Recommend Favorite

An emerging role for calcium sensitisation in the treatment of heart failure

By Erhardt Leif  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 6, 2005-06 ,pp. : 659-670

Informa Healthcare

Access to resources Recommend Favorite

Drug Treatment of Stable Angina Pectoris in the Elderly: Defining the Place of Calcium Channel Antagonists

By Kumar S.   Hall R.J.C.  

Drugs & Aging, Vol. 20, Iss. 11, 2003-01 ,pp. : 805-815

Adis International

Access to resources Recommend Favorite

Diuretic Therapy in Elderly Heart Failure Patients With and Without Left Ventricular Systolic Dysfunction

By van Kraaij D.J.W.  

Drugs & Aging, Vol. 16, Iss. 4, 2000-04 ,pp. : 289-300

Adis International

Access to resources Recommend Favorite